Andrea Gentili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Andrea Gentili has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
S Baroncini
5 shared publicationsM Lima
4 shared publicationsMario Lima
Department of Surgical Paediatrics; S.Orsola-Malpighi Hospital - Bologna University; Bologna Italy
4 shared publicationsSimonetta Baroncini
Department of Paediatric Anaesthesia and Intensive Care S.Orsola‐Malpighi Hospital – Bologna University Bologna Italy
4 shared publicationsL Giuntoli
3 shared publicationsS. Baroncini
Department of Paediatric Anaesthesia and intensive Care, S. Orsola-Malpighi Hospital, University of Bologna, Bologna
3 shared publications
Latest Publications
- Open Access
- 18 March 2025
- Published by Qeios Ltd in Qeios Preprints
Pioneering Spinal Anesthesia: A Historical Examination of Benedetto Schiassi’s Landmark Work
This article investigates the first documented use of spinal anesthesia in Italy, performed by surgeon Benedetto Schiassi in 1899. Faced with the limitations and risks of general anesthesia in a critically ill patient requiring urgent leg amputation, the surgeon employed cocaine as a local anesthetic, refining the technique with innovative modifications, including reduced dosage and prone positioning to mitigate adverse effects. Archival records and period medical publications highlight these refined techniques, contributing to the broader evolution of loco-regional anesthesia. Drawing from these historical sources, the article contextualizes Schiassi’s work within the global development of spinal anesthesia. His approach represents a significant milestone, influencing the adoption and evolution of spinal anesthesia as a safer and effective alternative to general anesthesia for surgery. By examining the broader historical and clinical significance of this event, the review highlights its impact on the trajectory of modern anesthesiology and surgical practices. This investigation offers insights into the interaction between innovation and historical medical contexts. It is intended to engage historians of medicine, anesthesiologists interested in the origins of their discipline, and surgeons involved in the evolution of anesthesiological practices useful for advances in surgical care.
- 18 March 2025
- Published by Qeios Ltd in Qeios Preprints
Open AccessPioneering Spinal Anesthesia: A Historical Examination of Benedetto Schiassi’s Landmark Work
This article investigates the first documented use of spinal anesthesia in Italy, performed by surgeon Benedetto Schiassi in 1899. Faced with the limitations and risks of general anesthesia in a critically ill patient requiring urgent leg amputation, the surgeon employed cocaine as a local anesthetic, refining the technique with innovative modifications, including reduced dosage and prone positioning to mitigate adverse effects. Archival records and period medical publications highlight these refined techniques, contributing to the broader evolution of loco-regional anesthesia. Drawing from these historical sources, the article contextualizes Schiassi’s work within the global development of spinal anesthesia. His approach represents a significant milestone, influencing the adoption and evolution of spinal anesthesia as a safer and effective alternative to general anesthesia for surgery. By examining the broader historical and clinical significance of this event, the review highlights its impact on the trajectory of modern anesthesiology and surgical practices. This investigation offers insights into the interaction between innovation and historical medical contexts. It is intended to engage historians of medicine, anesthesiologists interested in the origins of their discipline, and surgeons involved in the evolution of anesthesiological practices useful for advances in surgical care.
- 1 December 2023
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 90 (1-2) , 3-5
Lung-protective strategy during one-lung ventilation: current and future approaches to quantify the role of positive end-expiratory pressure
Article: Lung-protective strategy during one-lung ventilation: current and future approaches to quantify the role of positive end-expiratory pressure - Minerva Anestesiologica 2023 Dec 12 - Minerva Medica - Journals
- 1 December 2023
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 90 (1-2) , 3-5
Lung-protective strategy during one-lung ventilation: current and future approaches to quantify the role of positive end-expiratory pressure
Article: Lung-protective strategy during one-lung ventilation: current and future approaches to quantify the role of positive end-expiratory pressure - Minerva Anestesiologica 2023 Dec 12 - Minerva Medica - Journals
- Open Access
- 22 July 2022
- Published by Qeios Ltd
Review of: "Methadone: from Chronic Non-Oncological pain and primary Management Of Opioid Hyperalgesia to Disassuefaction Of Painkillers Abuse"
The manuscript presented by the authors is interesting and allows us to focus on many issues related to the use of methadone both in chronic pain and in the treatment of opioid addiction. The study can be published after a series of improvements to...
- 22 July 2022
- Published by Qeios Ltd
Open AccessReview of: "Methadone: from Chronic Non-Oncological pain and primary Management Of Opioid Hyperalgesia to Disassuefaction Of Painkillers Abuse"
The manuscript presented by the authors is interesting and allows us to focus on many issues related to the use of methadone both in chronic pain and in the treatment of opioid addiction. The study can be published after a series of improvements to...
- 1 October 2021
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 87 (10) , 1070-1072
Anesthesia in the elderly: an increasingly common practice
- 1 October 2021
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 87 (10) , 1070-1072
Anesthesia in the elderly: an increasingly common practice
- 1 April 2020
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 86 (4) , 374-376
Propofol: an intravenous anesthetic suitable for pediatric age
Article: Propofol: an intravenous anesthetic suitable for pediatric age - Minerva Anestesiologica 2020 April;86(4):374-6 - Minerva Medica - Journals
- 1 April 2020
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 86 (4) , 374-376
Propofol: an intravenous anesthetic suitable for pediatric age
Article: Propofol: an intravenous anesthetic suitable for pediatric age - Minerva Anestesiologica 2020 April;86(4):374-6 - Minerva Medica - Journals
- 1 December 2019
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 85 (12) , 1373-1374
December 27th, 1899-2019: the first spinal anesthesia in Italy is 120 years old
- 1 December 2019
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 85 (12) , 1373-1374
December 27th, 1899-2019: the first spinal anesthesia in Italy is 120 years old
- Open Access
- 1 October 2019
- Published by Scientific Scholar in Journal of Neurosciences in Rural Practice
- Vol. 10 (04) , 646-647
Pregabalin: A Drug Useful in the Management of Pain after Craniotomy?
In the last years, postoperative analgesia has made significant progress as new drugs and new pharmacological techniques have emerged. Progressively, these acquisitions have also critically reconsidered the established habit of treating postoperative pain only with nonsteroidal anti-inflammatory drugs or opioids.[1] Multimodal analgesia involves the use of multiple, simultaneous mechanisms of pain control acting synergistically to improve analgesic effect and reduce the doses of any single drug to minimize risks of side effects.[2] Closely related to multimodal analgesia, the concept of obtaining a better efficacy of postoperative analgesia has become increasingly more important, aiming above all at the specific type of surgery and the profile of the individual patient. In this issue of the Journal of Neurosciences in Rural Practice, the authors present a topic that is part of this new and interesting line of research.[3] It proposes a randomized, double-blind, placebo-controlled trial of notable relevance and importance in both cultural clarification and practical clinical use: the effect of pregabalin on postcraniotomy pain in patients undergoing supratentorial tumor surgery. Pregabalin belongs, together with gabapentin, to the class of drugs called gabapentinoids, originally designed as analogs of gamma-aminobutyric acid, which exert their analgesic effect through the mechanism of the bind to the α2 δ-1 and α2 δ-2 auxiliary subunits of calcium channels. Such action results in a reduction in the depolarization-induced influx of calcium; hence, there is a reduction in the release of excitatory neurotransmitters including glutamate, noradrenaline, dopamine, and serotonin.[4] Compared with gabapentin, pregabalin is considered more potent, is associated with fewer adverse effects, is more effective as it is absorbed more quickly, and shows higher biological activity. The study presented by the authors in this issue starts from two fundamental assumptions: the awareness that very often, the analgesic therapy after craniotomy is insufficient, and the need to use an analgesic strategy suitable for neurosurgery. Paradoxically, the organ that is the center of pain and its related mechanisms receives little attention to alleviate distress during neurosurgical procedures. From 30 to 90% of patients who reported postcraniotomy pain, the majority occurred in the first 48 hours after surgery.[5] The literature indicates that a valid postoperative analgesic strategy in this particular type of surgery must comply with some of the following criteria[6]: These features suggest that pregabalin, chosen in the protocol of this study and long used in the treatment of neuropathic pain, could be proposed in the analgesic strategy after neurosurgery, in which experiences are still scarce. The authors of the experience proposed in the current issue compare three groups of patients receiving oral placebo, pregabalin 75 mg, or pregabalin 150 mg before the induction of anesthesia, respectively. The result of the study is highly significant as it allows us to establish the threshold dose of 150 mg as effective, safe, with few sedation consequences, and with opioid-sparing effects. Doses as low as 75 mg give poor analgesic results. It should be noted that these data are also confirmed in other types of surgery.[7] In neurosurgery, another study on the management of pain after craniotomy with pregabalin shows that preoperative use of 150 mg on the evening before surgery, 1.5 hours before entering the operating room, and postoperative twice daily for 72 hours following surgery attenuates preoperative anxiety, improves sleep quality, reduces postoperative pain scores, and reduces analgesic usage without increasing the rate of adverse effects.[8] It should be stressed that the approach of this study, compared with that proposed in the current issue, differs above all in the daily dose and duration of administration of pregabalin. This condition must, however, be assessed, since in other types of surgery, the administration of pregabalin at doses higher than 150 mg/day or extended to the early postoperative days can cause an increase in sedation; this is considered a potential danger in neurosurgery. In conclusion, postoperative pain management after craniotomy needs to be effective and safe. it must avoid both the harmful effects of pain on brain cells and the side effects of drugs that can distort or harm the monitoring of the neurological examination. Pregabalin administered preoperatively may have a very important role in analgesic therapy. Further studies may serve to determine the risk/benefit ratio in being able to continue administration in the postoperative period.
- 1 October 2019
- Published by Scientific Scholar in Journal of Neurosciences in Rural Practice
- Vol. 10 (04) , 646-647
Open AccessPregabalin: A Drug Useful in the Management of Pain after Craniotomy?
In the last years, postoperative analgesia has made significant progress as new drugs and new pharmacological techniques have emerged. Progressively, these acquisitions have also critically reconsidered the established habit of treating postoperative pain only with nonsteroidal anti-inflammatory drugs or opioids.[1] Multimodal analgesia involves the use of multiple, simultaneous mechanisms of pain control acting synergistically to improve analgesic effect and reduce the doses of any single drug to minimize risks of side effects.[2] Closely related to multimodal analgesia, the concept of obtaining a better efficacy of postoperative analgesia has become increasingly more important, aiming above all at the specific type of surgery and the profile of the individual patient. In this issue of the Journal of Neurosciences in Rural Practice, the authors present a topic that is part of this new and interesting line of research.[3] It proposes a randomized, double-blind, placebo-controlled trial of notable relevance and importance in both cultural clarification and practical clinical use: the effect of pregabalin on postcraniotomy pain in patients undergoing supratentorial tumor surgery. Pregabalin belongs, together with gabapentin, to the class of drugs called gabapentinoids, originally designed as analogs of gamma-aminobutyric acid, which exert their analgesic effect through the mechanism of the bind to the α2 δ-1 and α2 δ-2 auxiliary subunits of calcium channels. Such action results in a reduction in the depolarization-induced influx of calcium; hence, there is a reduction in the release of excitatory neurotransmitters including glutamate, noradrenaline, dopamine, and serotonin.[4] Compared with gabapentin, pregabalin is considered more potent, is associated with fewer adverse effects, is more effective as it is absorbed more quickly, and shows higher biological activity. The study presented by the authors in this issue starts from two fundamental assumptions: the awareness that very often, the analgesic therapy after craniotomy is insufficient, and the need to use an analgesic strategy suitable for neurosurgery. Paradoxically, the organ that is the center of pain and its related mechanisms receives little attention to alleviate distress during neurosurgical procedures. From 30 to 90% of patients who reported postcraniotomy pain, the majority occurred in the first 48 hours after surgery.[5] The literature indicates that a valid postoperative analgesic strategy in this particular type of surgery must comply with some of the following criteria[6]: These features suggest that pregabalin, chosen in the protocol of this study and long used in the treatment of neuropathic pain, could be proposed in the analgesic strategy after neurosurgery, in which experiences are still scarce. The authors of the experience proposed in the current issue compare three groups of patients receiving oral placebo, pregabalin 75 mg, or pregabalin 150 mg before the induction of anesthesia, respectively. The result of the study is highly significant as it allows us to establish the threshold dose of 150 mg as effective, safe, with few sedation consequences, and with opioid-sparing effects. Doses as low as 75 mg give poor analgesic results. It should be noted that these data are also confirmed in other types of surgery.[7] In neurosurgery, another study on the management of pain after craniotomy with pregabalin shows that preoperative use of 150 mg on the evening before surgery, 1.5 hours before entering the operating room, and postoperative twice daily for 72 hours following surgery attenuates preoperative anxiety, improves sleep quality, reduces postoperative pain scores, and reduces analgesic usage without increasing the rate of adverse effects.[8] It should be stressed that the approach of this study, compared with that proposed in the current issue, differs above all in the daily dose and duration of administration of pregabalin. This condition must, however, be assessed, since in other types of surgery, the administration of pregabalin at doses higher than 150 mg/day or extended to the early postoperative days can cause an increase in sedation; this is considered a potential danger in neurosurgery. In conclusion, postoperative pain management after craniotomy needs to be effective and safe. it must avoid both the harmful effects of pain on brain cells and the side effects of drugs that can distort or harm the monitoring of the neurological examination. Pregabalin administered preoperatively may have a very important role in analgesic therapy. Further studies may serve to determine the risk/benefit ratio in being able to continue administration in the postoperative period.
- 1 October 2019
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 85 (10) , 1050-1052
Is regional analgesia useful in pain management of intensive care patients?
- 1 October 2019
- Published by Edizioni Minerva Medica in Minerva Anestesiologica
- Vol. 85 (10) , 1050-1052
Is regional analgesia useful in pain management of intensive care patients?
- 1 May 2018
- Published by Wiley in Pediatric Anesthesia
- Vol. 28 (5) , 476-477
Perioperative intravenous pediatric fluid: is there still a gap between theory and practice?
- 1 May 2018
- Published by Wiley in Pediatric Anesthesia
- Vol. 28 (5) , 476-477
Perioperative intravenous pediatric fluid: is there still a gap between theory and practice?
- 7 December 2016
- Published by Springer Nature
- p. 99-112
Intensive Care in Digestive Surgery